Addressing instability with Modular Dual Mobility and Novae Monobloc Dual Mobility
Program objectives
- Evaluate and identify common indications for using dual mobility
- Understand the difference in clinical benefits between monobloc and modular dual mobility
- Identify cases in which cemented dual mobility is an appropriate treatment solution
Product focus
- Modular Dual Mobility (MDM)
- Novae Monobloc Dual Mobility
Joseph Nessler, M.D.
St. Cloud, MN
Residency: Mayo Clinic
Benjamin Wooster, M.D.
Charlotte, NC
Residency: Duke University Medical Center
Fellowship: Mayo Clinic
Join Joseph Nessler, M.D. and Benjamin Wooster, M.D. as they discuss how to evaluate and identify common indications for using dual mobility in total hip arthroplasty
RESOURCES
The faculty are paid consultants of Stryker Orthopaedics. The opinions expressed by the faculty are those of the faculty and not necessarily those of Stryker. Individual experiences may vary.
The material presented is intended for educational purposes only. A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery. Stryker does not endorse or support the unapproved uses of its products.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: MDM, Novae, Stryker. All other trademarks are trademarks of their respective owners or holders.
JR-GSNPS-SYK-774781